Fadwa Mostafa Arafa

Fadwa Mostafa Arafa

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in Parasitology Research
Verified
Journal Article
Open access
PDF file
FAFadwa Mostafa Arafa
Fadwa Mostafa Arafa
DODoaa Hassan Osman
Doaa Hassan Osman
MTMona Mohamed Tolba
Mona Mohamed Tolba
NRNadjet Rezki
Nadjet Rezki
MAMohamed R Aouad
Mohamed R Aouad
HSHeba Said
Heba Said
Toxoplasmosis is an infection that prevails all over the world and is caused by the obligate intracellular protozoan parasite Toxoplasma gondii (T. gondii). Promising novel compounds for the treatment of T. gondii are introduced in the current investigation. In order to test their in vitro potency against T. gondii tachyzoites, six 1,2,3-triazoles-based sulfonamide scaffolds with terminal NH2 or OH group were prepared and investigated as sulfadiazine equivalents. When compared to sulfadiazine, which served as a positive control, hybrid molecules showed much more anti-Toxoplasma activity. The results showed that the IC50 of the examined compounds 3(a–f) were recoded as 0.07492 μM, 0.07455 μM, 0.0392 μM, 0.03124 μM, 0.0533 μM, and 0.01835 μM, respectively, while the sulfadiazine exhibited 0.1852 μM. The studied 1,2,3-triazole-sulfadrug molecular conjugates 3(a–f) revealed selectivity index of 10.4, 8.9, 25.4, 21, 8.3, and 29; respectively. The current study focused on the newly synthesized amino derivatives 3(d–f), as they contain the more potent amino groups which are recognized to be essential elements and promote better biological activity. Extracellular tachyzoites underwent striking morphological alterations after 2 h of treatment as seen by scanning electron microscopy (SEM). Additionally, the intracellular tachyzoite exposed to the newly synthesized amino derivatives 3(d–f) for a 24-h period of treatment revealed damaged and altered morphology by transmission electron microscopic (TEM) indicating cytopathic effects. Moreover, compound 3f underwent the most pronounced changes, indicating that it had the strongest activity against T. gondii.

13 November 2024 in Acta Tropica
Verified
Journal Article
Closed access
FAFadwa Mostafa Arafa
Fadwa Mostafa Arafa
NHNehal N. Hezema
Nehal N. Hezema
AAAteyatallah Aljuhani
Ateyatallah Aljuhani
MAMohamed R. Aouad
Mohamed R. Aouad
MHMohamed Hagar
Mohamed Hagar
SSSara A. Abdel Salam
Sara A. Abdel Salam

Verified
Journal Article
Open access
PDF file
DSDoaa E. Said
Doaa E. Said
EAEglal I. Amer
Eglal I. Amer
Eman ShetaEman Sheta
Eman Sheta
SMShaimaa Osama Makled
Shaimaa Osama Makled
HDHala E. Diab
Hala E. Diab
FAFadwa Mostafa Arafa
Fadwa Mostafa Arafa
Melatonin (MLT) is now emerging as one of the universally accepted immunostimulators with broad applications in medicine. It is a biological manipulator of the immune system, including mucosal ones. MLT was encapsulated in solid lipid nanoparticles (SLNs), then 100 mg/kg/dose of MLT-SLNs was used as an adjuvant of Toxoplasma lysate antigen (TLA). Experimental mice were intra-nasally inoculated with three doses of different regimens every two weeks, then challenged with 20 cysts of T. gondii Me49 strain, where they were sacrificed four weeks post-infection. Protective vaccine efficacy was evident via the significant brain cyst count reduction of 58.6%, together with remarkably high levels of humoral systemic and mucosal anti-Toxoplasma antibodies (Ig G, Ig A), supported by a reduced tachyzoites invasion of Vero cells in vitro upon incubation with sera obtained from these vaccinated mice. A cellular immune response was evident through the induction of significant levels of interferon-gamma (IFN γ), associated with morphological deteriorations of cysts harvested from the brains of vaccinated mice. Furthermore, the amelioration of infection-induced oxidative stress (OS) and histopathological changes were evident in mice immunized with TLA/MLT-SLNs. In conclusion, the present study highlighted the promising role of intranasal MLT-SLNs as a novel mucosal adjuvant candidate against chronic toxoplasmosis.

Verified
Journal Article
Open access
PDF file
DSDoaa E. Said
Doaa E. Said
EAEglal I. Amer
Eglal I. Amer
Eman ShetaEman Sheta
Eman Sheta
SMShaimaa Osama Makled
Shaimaa Osama Makled
FAFadwa Mostafa Arafa
Fadwa Mostafa Arafa
HDHala E. Diab
Hala E. Diab
The tight relationship between immunity and retinoid levels provides evidence on the critical role of retinoic acid (RA) in regulating immune activity, especially the mucosal one. Mucosal immune response is the key for determination of the outcome of infection, particularly against intracellular mucosal pathogens such as Toxoplasma gondii, where it plays a crucial role as a sentinel against parasite invasion. Herein, the immunomodulatory adjuvant role of RA was evaluated for prophylactic vaccination against chronic Toxoplasma infection. A quantity of 15 µg of RA pre-encapsulated with lipid-based nanoparticles (SLNs) was intranasally used in three doses, two weeks apart, as an adjuvant to the Toxoplasma lysate antigen (TLA). Afterward, mice were infected with 20 cysts of T. gondii (ME49 strain) and were sacrificed at the 4th week post-infection. Parasitological, immunological, biochemical, and histopathological studies were applied as vaccine efficacy measures. The protective role of the tested vaccine was noted using the statistically marked reduction in brain cyst count, accompanied by remarkable levels of protective IFN-γ and antibodies, with amelioration of infection-induced oxidative stress and brain pathology. Ultimately, this experiment outlined the prospective role of a novel, natural, nano-encapsulated and mucosal vaccine adjuvant RA-SLNs as a propitious candidate against chronic toxoplasmosis.

Verified
Journal Article
Open access
PDF file
FAFadwa Mostafa Arafa
Fadwa Mostafa Arafa
HSHeba Said
Heba Said
DODoaa Osman
Doaa Osman
NRNadjet Rezki
Nadjet Rezki
MAMohamed Reda Aouad
Mohamed Reda Aouad
MTMona Mohamed Tolba
Mona Mohamed Tolba
Toxoplasma gondii is deemed a successful parasite worldwide with a wide range of hosts. Currently, a combination of pyrimethamine and sulfadiazine serves as the first-line treatment; however, these drugs have serious adverse effects. Therefore, it is imperative to focus on new therapies that produce the desired effect with the lowest possible dose. The designation and synthesis of sulfonamide-1,2,3-triazole hybrids (3a–c) were performed to create hybrid frameworks. The newly synthesized compounds were loaded on chitosan nanoparticles (CNPs) to form nanoformulations (3a.CNP, 3b.CNP, 3c.CNP) for further in vitro investigation as an anti-Toxoplasma treatment. The current study demonstrated that all examined compounds were active against T. gondii in vitro relative to the control drug, sulfadiazine. 3c.CNP showed the best impact against T. gondii with the lowest IC50 value of 3.64 µg/mL. Using light microscopy, it was found that Vero cells treated with the three nanoformulae showed remarkable morphological improvement, and tachyzoites were rarely seen in the treated cells. Moreover, scanning and transmission electron microscopic studies confirmed the efficacy of the prepared nanoformulae on the parasites. All of them caused parasite ultrastructural damage and altered morphology, suggesting a cytopathic effect and hence confirming their promising anti-Toxoplasma activity.

23 August 2025 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
MEMarwa Eltarahony
Marwa Eltarahony
SYSalwa S. Younis
Salwa S. Younis
SSSara A. Abdel Salam
Sara A. Abdel Salam
FAFadwa Mostafa Arafa
Fadwa Mostafa Arafa
Background: Tackling the high demand for alternative therapeutic options, especially for multi-drug-resistant organisms, has awakened interest in naturally originated biomolecules such as pyocyanin (PYO). Herein, PYO-producing bacterium was isolated and PYO was extracted, characterized, and its antagonistic potency was scrutinized against a vast array of prokaryotic and eukaryotic water pathogens, either in free-living or biofilm lifestyles, both in vitro and in vivo. Results: Initially, Pseudomonas sp. MPF-2 that was screened from agricultural soil for PYO production, was characterized and identified. On King’s-A broth, the maximum productivity of PYO recorded 31.35 µg\ mL within 72 h. Subsequently, the extracted PYO exhibited maximum absorbance peaks at 277, 383 and 522 nm using UV–vis spectrophotometry. While FTIR spectrum accentuated the involvement of the main hallmark functional groups that characterize phenazine including O–H, C = N, aromatic C-H, C = C, CH3, C-O and C– O–C. Additionally, GC-MS analysis showed the major peaks of 1-hydroxyphenazine (hemi pyocyanin) and phenazine fractions at 206.1, 196.1 and 168.1 m/z. Upon employing it as an antibacterial agent, the crude PYO showed the lowest MIC (15.6 µg/mL) against S. pneumoniae , the highest MIC (500 µg/mL) versus P. vulgaris . While a considerable mycocidal potency was noticed against C. albicans and C. tropicalis at 125 and 62.5 µg/mL, respectively. As an antibiofilm agent, PYO displayed 98.11 ± 1.7, 88.04 ± 1.37 and 90.99 ± 2.13% inhibition for B. cereus , P. vulgaris and C. albicans biofilms, in that same order. Whereas, 61.65 ± 2.09, 40.86 ± 2.81 and 48.68 ± 2.56% eradication was detected at 1000 µg/mL for the pre-established biofilms of B. cereus , P. vulgaris and C. albicans , sequentially. Meanwhile, it didn’t show any significant toxicity regarding serum kidney and liver functions in orally treated mice at 25 mg/kg for 5 days. For antiparasitic potency, PYO-treated mice, at the juvenile stage, exhibited a significant reduction ( p ≤ 0.05) in the total worm load (23.83 ± 2.79), with a reduction percentage of 34.41%, while PZQ-treated mice failed to show any significant reduction. Moreover, SEM micrographs emphasized the ultrastructural changes in S. mansoni juvenile and adult worms recovered from the PYO-treated mice. To the best of our knowledge, this is the first in vivo study to assess orally administered PYO as a therapeutic option against S. mansoni. Conclusion: The promising results encourage the recruiting of PYO in conquering the virulence of other pathogens in different environmental, medical and industrial applications.